Does AREDS2 work in dry age-related macular degeneration?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The AREDS2 supplement appears to modestly slow the progression of intermediate dry AMD, especially in patients already at higher risk, but does not affect early-stage progression.

Fields of Study & Subjects

Retinal Diseases and Treatments Retinal Imaging and Analysis Ocular Surface and Contact Lens

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 March 2026
Language
EN